MicroRNA alterations in head and neck squamous cell carcinomal

被引:211
作者
Chang, Steven S. [1 ]
Jiang, Wei Wen [2 ]
Smith, Ian [1 ]
Poeta, Luana M. [3 ]
Begum, Shahnaz [4 ]
Glazer, Chad
Shan, Shannon [5 ]
Westra, William [4 ]
Sidransky, David [1 ]
Califano, Joseph A. [1 ,6 ]
机构
[1] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA
[2] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 9, Dept Oral Mucosal Dis, Shanghai 200030, Peoples R China
[3] Univ Campus Biomed Rome, Ctr Integrated Res, Lab Mol Med & Biotechnol, Rome, Italy
[4] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[6] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA
关键词
microRNA; HNSCC; mir-21; mir-494; mir; squamous cell cancer;
D O I
10.1002/ijc.23831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (mirs) are small noncoding RNA molecules (similar to 22 nocleotides) that regulate posttranscriptional gene expression. Currently, there has not been a comprehensive study of their role in primary head and neck squamous cell carcinoma (HNSCC). To determine the role of mirs in HNSCC, we screened for altered microRNA expression in HNSCC primary tissue and cell lines. We then further tested the functional impact of alterations of specific mirs. An initial screening of 4 primary HNSCC, 4 normal mucosal controls and 4 HNSCC cell lines was analyzed for mature microRNA expression by microarray. Significance was determined using significance analysis of microarrays (SAM). Nine microRNAs were found by SAM to be upregulated or downregulated in tumor tissue including mir-21, let-7, 18, 29c, 142-3p, 155, 146b (overexpressed) and 494 (underexpressed). Mir-21 was validated by qRT-PCR. Functional validation by growth assays was performed, further validating mir-21. Transfection of mir-21 into JHU-011 and JHU-012 cell lines showed a 39% increase in cell growth at 72 hr relative to controls (p < 0.05). Transfection of the inhibitor into JHU-012 cell lines showed a 92% decrease in cell growth relative to controls at 72 hr (p < 0.05). In addition, flow cytometry analysis of JHU-012 cells 48 hr after mir-21 inhibitor transfection showed a statistically significant increase in cytochrome c release and increased apoptosis. These differentially expressed microRNAs may be of interest as potential novel oncogenes and tumor suppressor genes in HNSCC. Mir-21 is a putative oncogenic microRNA in head and neck cancer. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:2791 / 2797
页数:7
相关论文
共 28 条
  • [1] MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
    Calin, GA
    Liu, CG
    Sevignani, C
    Ferracin, M
    Felli, N
    Dumitru, CD
    Shimizu, M
    Cimmino, A
    Zupo, S
    Dono, M
    Dell'Aquila, ML
    Alder, H
    Rassenti, L
    Kipps, TJ
    Bullrich, F
    Negrini, M
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) : 11755 - 11760
  • [2] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [3] Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database
    Carvalho, AL
    Nishimoto, IN
    Califano, JA
    Kowalski, LP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (05) : 806 - 816
  • [4] MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
    Chan, JA
    Krichevsky, AM
    Kosik, KS
    [J]. CANCER RESEARCH, 2005, 65 (14) : 6029 - 6033
  • [5] MicroRNAs are aberrantly expressed in hypertrophic heart - Do they play a role in cardiac hypertrophy?
    Cheng, Yunhui
    Ji, Ruirui
    Yue, Junming
    Yang, Jian
    Liu, Xiaojun
    Chen, He
    Dean, David B.
    Zhang, Chunxiang
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (06) : 1831 - 1840
  • [6] miRNAs, cancer, and stem cell division
    Croce, CM
    Calin, GA
    [J]. CELL, 2005, 122 (01) : 6 - 7
  • [7] Sequence variations of microRNAs in human cancer: Alterations in predicted secondary structure do not affect processing
    Diederichs, Sven
    Haber, Daniel A.
    [J]. CANCER RESEARCH, 2006, 66 (12) : 6097 - 6104
  • [8] Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
    Fulci, Valerio
    Chiaretti, Sabina
    Goldoni, Marina
    Azzalin, Gianluca
    Carucci, Nicoletta
    Tavolaro, Simona
    Castellano, Leandro
    Magrelli, Armando
    Citarella, Franca
    Messina, Monica
    Maggio, Roberta
    Peragine, Nadia
    Santangelo, Simona
    Mauro, Francesca Romana
    Landgraf, Pablo
    Tuschl, Thomas
    Weir, David B.
    Chien, Minchen
    Russo, James J.
    Ju, Jingyue
    Sheridan, Robert
    Sander, Chris
    Zavolan, Mihaela
    Guarini, Anna
    Foa, Robin
    Macino, Giuseppe
    [J]. BLOOD, 2007, 109 (11) : 4944 - 4951
  • [9] MicroRNA signatures in human ovarian cancer
    Iorio, Marilena V.
    Visone, Rosa
    Di Leva, Gianpiero
    Donati, Valentina
    Petrocca, Fabio
    Casalini, Patrizia
    Taccioli, Cristian
    Volinia, Stefano
    Liu, Chang-Gong
    Alder, Hansjuerg
    Calin, George A.
    Menard, Sylvie
    Croce, Carlo M.
    [J]. CANCER RESEARCH, 2007, 67 (18) : 8699 - 8707
  • [10] MicroRNA gene expression deregulation in human breast cancer
    Iorio, MV
    Ferracin, M
    Liu, CG
    Veronese, A
    Spizzo, R
    Sabbioni, S
    Magri, E
    Pedriali, M
    Fabbri, M
    Campiglio, M
    Ménard, S
    Palazzo, JP
    Rosenberg, A
    Musiani, P
    Volinia, S
    Nenci, I
    Calin, GA
    Querzoli, P
    Negrini, M
    Croce, CM
    [J]. CANCER RESEARCH, 2005, 65 (16) : 7065 - 7070